PYC THERAPEUTICS LIMITED — Director's Dealing 2017

May 21, 2017

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity PHYLOGICA LIMITED ABN 48 098 391 961

We, Phylogica Limited, give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

for the director for the purposes of section	205G of the Corporations Act.
Name of Director	STEPHANIE UNWIN
Date of last notice	30 NOVEMBER 2016

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	DIRECT
Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise tothe relevant interest.
Date of change	19 MAY 2017
No. of securities held prior to change	10,000,000 UNLISTED OPTIONS, EXPIRY 3ONOVEMBER 2019, NIL EXERCISE PRICE
Class	ORDINARY SHARES, FULLY PAID
Number acquired	3,333,333
Nature of changeExample: on-market trade, off-market trade, exercise ofoptions, issue of securities under dividend reinvestmentplan, participation in buy-back	ISSUED UPON EXERCISE OF OPTIONS
Number disposed	NIL
Value/ConsiderationNote: If consideration is non-cash, provide details andestimated valuation	NIL EXERCISE PRICE
No. of securities held after change	3,333,333 ORDINARY SHARES6,666,667 UNLISTED OPTIONS, EXPIRY 30NOVEMBER 2019, NIL EXERCISE PRICE

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailedabove traded during a+closed period where priorwritten clearance was required?	N/A
If so, was prior written clearance provided to allow thetrade to proceed during this period?	N/A
If prior written clearance was provided, on what datewas this provided?	N/A

• See chapter 19 for defined terms. Appendix 3Y Page 2

01/01/2011